Albert Bourla - 30 Nov 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chairman & CEO, Director
Issuer symbol: PFE
Report date: 30 Nov 2022
Net transaction value: +$501
Form type: 4
Accepted by SEC: 01 Dec 2022, 15:01:44 UTC
Previous filing: 16 Nov 2022
Next filing: 16 Dec 2022
SEC filing: View on sec.gov
Reporting owner signature: Susan E. Grant, by power of atty., for Albert Bourla

Key filing fact

Albert Bourla filed Form 4 for PFIZER INC (PFE) on 01 Dec 2022.

Key facts

This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Dec 2022, 15:01.

Change

Previous filing in this sequence was filed on 16 Nov 2022.
Current net transaction value: +$501.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Phantom Stock Units SSP

Award

Transaction value: $501
Shares: +10
Change %: +0.01%
Price: $50.13
Shares after: 96,419
Date: 30 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each unit represents one phantom share of common stock.

Footnote F2

These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.